Unusual bleeds, unusual clots

Hamostaseologie

Volumn 27, Issue 3, 2007, Pages 191-199

  Moll, Stephan ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Bleeding; Coagulation; Factor VIII inhibitor; Gardner Diamond syndrome; Haemophilia; Lymphoedema; Nephrogenic fibrosing dermopathy; Pseudotumour; Purple toe syndrome; Thrombosis; Vena cava syndrome; Von Willebrand factor inhibitor; Warfarin skin necrosis

Indexed keywords

ANTIVITAMIN K; BLOOD CLOTTING FACTOR 8 CONCENTRATE; BLOOD CLOTTING FACTOR 8 INHIBITOR; COUMARIN; HEPARIN; RITUXIMAB; WARFARIN;

BLEEDING; BLOOD CLOTTING; BLOOD CLOTTING DISORDER; BRACHIOCEPHALIC VEIN; BREAST AUGMENTATION; DEEP VEIN THROMBOSIS; DIAGNOSTIC PROCEDURE; DIAGNOSTIC TEST; ECCHYMOSIS; GARDNER SYNDROME; HEMATOMA; HEMOPHILIA A; HEPARIN INDUCED THROMBOCYTOPENIA; HUMAN; LABORATORY TEST; LEG SWELLING; LYMPHEDEMA; NEPHROGENIC FIBROSING DERMOPATHY; PSEUDOTUMOR; PURPLE TOE SYNDROME; REVIEW; SKIN NECROSIS; THROMBOSIS; VEIN THROMBOSIS; VON WILLEBRAND DISEASE; AGED; ARTICLE; BLEEDING TIME; BLOOD; CASE REPORT; CLASSIFICATION; FEMALE; PARTIAL THROMBOPLASTIN TIME;

AGED; BLEEDING TIME; BLOOD COAGULATION; BLOOD COAGULATION DISORDERS; ECCHYMOSIS; FEMALE; HUMANS; PARTIAL THROMBOPLASTIN TIME; VON WILLEBRAND DISEASE;

EID: 34848871076     PISSN: 07209355     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1616911     Document Type: Review

References (22)

1. Hay CR, Brown S, Collins PW et al. The diagnosis and management of factor VIII and IX inhibitors: a guideline from the United Kingdom Haemophilia Centre Doctors Organisation. Br J Haematol 2006; 133: 591-605.
2. Franchini M. Acquired hemophilia A. Hematology 2006; 11: 119-25.
3. Moll S, Fuller E, Cassara J et al. Acquired von Willebrand's disease not responding to Rituximab. J Thromb Haemost 2003; 1(suppl 1): CD050.
4. Rogers JL, Moll S. Pseudotumour in haemophilia A. Br J Haematol 2007; 136: 519.
5. Magallon M, Monteagudo J, Altisent C et al. Hemophilic pseudotumor: multicenter experience over a 25-year period. Am J Hematol 1994; 45: 103-108.
6. Moll S. Psychogenic purpura. Am J Hematol 1997; 55: 146-147.
7. Ratnoff OD. Psychogenic purpura (autoerythrocyte sensitization): an unsolved dilemma. Am J Med 1989; 87: 16N-21N.
8. Behrendt C, Goos M, Thiel H et al. Painful bruising syndrome. Hautarzt 2001; 52: 634-637.
9. Moll S. Warfarin-induced skin necrosis. Br J Haematol 2004; 126: 628.
10. Warkentin TE, Sikov WM, Lillicrap DP. Multicentric warfarin-induced skin necrosis complicating heparin-induced thrombocytopenia. Am J Hematol 1999; 62: 44-48.
11. Isenberg JS, Tu Q, Rainey W. Mammary gangrene associated with warfarin ingestion. Ann Plast Surg 1996; 37: 553-555.
12. Stirling Y. Warfarin-induced changes in procoagulant and anticoagulant proteins. Blood Coagul Fibrinolysis 1995; 6: 361-373.
13. Sallah S, Thomas DP, Roberts HR. Warfarin and heparin-induced skin necrosis and the purple toe syndrome: infrequent complications of anticoagulant treatment. Thromb Haemost 1997; 78: 785-790.
14. Moll S, Huffman J. Cholesterol emboli associated with warfarin treatment. Am J Hematol 2004; 77: 194-195.
15. Wright RS, Quinones-Baldrich WJ, Anders AJ et al. Pleural effusion associated with ipsilateral breast and arm edema as a complication of subclavian vein catheterization and arteriovenous fistula formation for hemodialysis. Chest 1994; 106: 950-952.
16. Schiffer JT, Jefferson BK. Cases from the Osler Medical Service at Johns Hopkins University. Am J Med 2003; 115: 404-406.
17. Nephrogenic fibrosing dermopathy associated with exposure to gadolinium-containing contrast agents - St. Louis, Missouri, 2002-2006. MMWR Morb Mortal Wkly Rep 2007; 56: 137-141.
18. Lim YL, Lee HY, Low SC et al. Possible role of gadolinium in nephrogenic systemic fibrosis: report of two cases and review of the literature. Clin Exp Dermatol 2007; 32: 353-358
19. Scheinfeld N. Nephrogenic fibrosing dermopathy: a comprehensive review for the dermatologist. Am J Clin Dermatol 2006; 7: 237-47.
20. http://www.icnfdr.org (last accessed May 2, 2007).
21. Tiwari A, Cheng KS, Button M, Myint F, Hamilton G. Differential diagnosis, investigation, and current treatment of lower limb lymphedema. Arch Surg 2003; 138: 152-161.
22. Carver C, Brice G, Mansour S et al. Three children with Milroy disease and de novo mutations in VEGFR3. Clin Genet 2007; 71: 187-189.